|
|
|
|
|
|
Rexahn Pharmaceuticals (RNN)
|
|
1.95 +0.03 (+1.56%)
|
8/16/2017 4:00pm
|
|
Open:
|
1.94
|
Pre. Close:
|
1.92
|
|
High:
|
2.04
|
Low:
|
1.90
|
|
Volume:
|
109,091
|
Market Cap:
|
55.50M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.08 - 2.12
|
2.12 - 2.2
|
|
Low:
|
1.8 - 1.82
|
1.82 - 1.87
|
|
Close:
|
1.88 - 1.94
|
1.94 - 2.06
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-16 4:46:24 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 2.63 One year: 3.03
|
|
Support:
|
Support1: 1.70 Support2: 1.41
|
|
Resistance:
|
Resistance1:
2.25 Resistance2: 2.59
|
|
Pivot:
|
1.96 
|
|
Moving Averages:
|
MA(5): 1.91  MA(20): 2.05
MA(100): 2.25 MA(250): 1.03
|
|
MACD:
|
MACD(12,26):
-0.17 Signal(12,26,9): -0.20
|
|
%K %D:
|
%K(14,3): 36.37 %D(3): 32.15
|
|
RSI:
|
RSI(14): 38.70
|
|
52-Week:
|
High: 7.10
Low: 0.38 Change(%): 650.0
|
|
Average Vol(K):
|
3-Month: 22744
10-Days 10014
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.RNN has closed above bottom band by 47.6%. Bollinger Bands are 59.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to RNN's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Mon, 17 Apr 2017 15:33:45 GMT
Could Rexahn Pharmaceuticals Have Something?
Mon, 14 Aug 2017 12:56:15 GMT
Rexahn Pharmaceuticals Issues Mid-Year Shareholder Letter to Review Recent ...
Mon, 08 May 2017 12:56:15 GMT
Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American ...
Thu, 17 Aug 2017 00:56:15 GMT
Rexahn Pharmaceuticals Inc (RNN) Seeing Increased Action in Session
Mon, 10 Jul 2017 12:56:15 GMT
Rexahn Pharmaceuticals Receives Notice of Allowance for a New US Patent ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
